Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Pioneer Group and Science Creates Announce Strategic Collaboration to Accelerate Science and Tech Ventures

Pioneer Group and Science Creates today announce a new partnership that will support the next generation of science and technology ventures across the UK and Ireland.

The collaboration brings together two mission-led organisations committed to helping founders translate scientific discovery into commercial solutions to tackle some of the most pressing challenges in human and planetary health.

Exceptional Transfection Reagent for Widest Range of Cell Lines

GenePORTER® Gold from Amsbio is a highly reproducible, lipid-based gene transfection reagent delivering exceptional efficiency across the widest range of cell lines. Utilizing proprietary Advanced Carrier Enhancement (ACE) technology - GenePORTER® Gold delivers outstanding transfection efficiency and transgene expression levels with minimal cytotoxicity.

High Purity Exosome Standards Enhance Research Reproducibility

Amsbio offers a wide range of highly pure, lyophilized exosome standards designed to support reproducibility and standardization in extracellular vesicle (EV) research.
Exosomes are small lipid nanoparticles actively secreted by exocytosis in most living cells. Regulating pleiotropic physiological and pathological functions – exosomes have been shown to play significant roles in diverse pathological conditions such as cancer, infectious and neurodegenerative diseases. Currently there is growing interest in exosomes as promising new tools for use such as biomarkers and therapeutics.

£1m Funding for Innovative Drug Discovery Projects in Collaboration with Medicines Discovery Catapult

Two groundbreaking drug discovery projects, supported by Medicines Discovery Catapult (MDC), have secured over £1m in funding from Innovate UK's Launchpad Northern Ireland programme.

SignaCor Therapeutics and Klas Therapeutics, both based in Northern Ireland, have been awarded a share of funding from the Launchpad programme.

The funding provides a vital boost to the SMEs' research programmes, which focus on innovations to treat heart disease and skin cancer.

Coulter Partners places Non-executive Director at Australian life sciences company, QBiotics Group Ltd

LONDON, UK, and MELBOURNE, Australia, July 15, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for QBiotics Group Limited (QBiotics) and is pleased to announce the placement of Sergio Duchini as Non-executive Director.

Cancer Research Horizons Innovation Summit 2025

The Innovation Summit provides researchers with a great opportunity to connect with the community, expand their network and build their entrepreneurship skills by bringing together inspiring guests, field-leading speakers and thought-provoking panellists.

This free, one-day event offers invaluable insights from industry leaders, networking opportunities with fellow innovators, and the chance to learn essential entrepreneurial skills.

6 Key Lab Supply Sourcing Pain Points...and How a Marketplace Solves Them

In 2023, we surveyed hundreds of research scientists, lab operations, and procurement professionals across various biotech and pharmaceutical R&D labs. The results painted a vivid picture of today’s lab supply procurement process’s inefficiency and the complexities of P2P/S2P implementation due to the uniqueness of the R&D space.

Join us for an insightful webinar as we delve into survey results and explore innovative marketplace solutions that address these issues head-on. During this webinar, you will learn how to:

ARECOR ESTABLISHES NEW SCIENTIFIC ADVISORY BOARD OF WORLD LEADING EXPERTS IN ORAL DRUG DELIVERY

Internationally recognised leaders will provide expert technical guidance to support Arecor in its mission to develop a game-changing oral delivery of peptides technology platform 

Cambridge, UK,14 July 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces the formation of its new Scientific Advisory Board of internationally recognised experts in the fields of oral drug delivery and peptide therapeutics.

Subscribe to